Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Adaptive Biotechnologies announced that its clonoSEQ next-generation sequencing test for measurable residual disease (MRD) continues to gain prominence across hematologic oncology clinical practice and research, with inclusion in 33 presentations at the 2026 ASCO and EHA meetings. Data underscore clonoSEQ’s key role in disease monitoring and treatm…
ZenaTech, a Nasdaq-listed technology company specializing in AI-powered drone solutions, announced plans to pursue investment opportunities with the U.S. Department of War and the Office of Strategic Capital. Following reports of increased U.S. government interest in domestic drone manufacturers, ZenaTech's subsidiary, ZenaDrone, highlighted its ND…
South Bow Corp., listed on both TSX and NYSE under ticker SOBO, announced the successful completion of its open season with firm 20-year commitments for transportation service from Hardisty, Alberta to U.S. delivery points. This milestone supports advancement of the Prairie Connector pipeline project aimed at improving market access for Western Can…
ParaZero Technologies Ltd. has engaged a subcontractor to establish a full-scale production line for its DefendAir counter-UAS net pod systems, increasing manufacturing, assembly, and delivery capacity to meet growing global demand from defense, law enforcement, and critical infrastructure sectors. This operational milestone aims to strengthen Para…
EDAP TMS S.A. announced it will rebrand as FocalTherics to emphasize its exclusive focus on the high-growth robotic focal therapy market. The company's ticker symbol on Nasdaq will change from EDAP to FOCL starting June 1, 2026. Legacy ESWL and distribution segments will be reported as discontinued operations beginning Q2 2026. An Investor Day even…
Build-A-Bear (BBW) faces near-term inflation-related headwinds, yet the company is highly profitable, debt-free, and generating healthy free cash flow. At roughly $38.90 today, BBW trades at single-digit P/E and an EV/EBITDA below 6, offering a favorable reward-to-risk for a tactical buy with defined stops and two time-based targets.
SoFi Technologies shares jumped in pre-market trading after its banking arm issued SoFiUSD, becoming the first U.S. national bank to offer a regulated stablecoin inside its app. The launch, combined with better-than-expected Q1 2026 results and reaffirmed 2026 guidance, has investors reassessing SoFi's positioning in digital assets and fee-based re…
Hewlett Packard Enterprise shares surged 18% on Friday and Super Micro Computer rose 10% after Dell Technologies reported a strong quarter and significantly raised its revenue and AI-server outlook. Dell's results, driven by demand for Nvidia-powered AI servers and supported by large data center customers, lifted sentiment across AI infrastructure …
Preliminary May data from the euro zone's four largest economies indicate headline inflation remained above the European Central Bank's 2% goal for a third consecutive month. A jump in fuel prices linked to the Iran war has begun to push up costs in transport, entertainment and fresh food in several countries, strengthening the case for an ECB rate…
SoFi Technologies shares rose 7% Friday morning following a 5% gain a day earlier after the company launched SoFiUSD, described as the first stablecoin issued by a U.S. national bank on a banking platform. The coin is redeemable 1:1 for U.S. dollars, will be available on major blockchain networks, and is being rolled out to the company’s nearly 15 …
Bank of England Governor Andrew Bailey said he welcomed financial markets scaling back expectations for further rate increases, but warned the path for policy depends on developments in the Middle East. He defended the decision to tolerate inflation above the 2% target while the economy softens, but said that tolerance would be withdrawn if evidenc…
Agios Pharmaceuticals' stock declined sharply after the company said a Phase 2b trial of tebapivat in lower-risk myelodysplastic syndromes (LR-MDS) did not meet the predefined criteria needed to support continued development in that indication. While the drug showed biological activity and was well tolerated, it failed to deliver clinical benefit i…
Futures on Canada's major stock gauge rose modestly after reports that the United States and Iran agreed to extend a ceasefire and relax shipping restrictions through the Strait of Hormuz, a move that eased risk sentiment. Oil prices fell and investors prepared for Canada’s first-quarter GDP release, while markets continued to price in a high proba…
China has signaled it could open trade investigations targeting the European Union at the same time EU officials meet to consider strengthening mechanisms to limit heavily subsidized imports. The exchange centers on a proposed 'overcapacity instrument' that would allow Brussels to cap imports and apply sector-wide tariffs, measures that would most …
Public Policy Holding Company, Inc. announced that its management team will participate in Stifel's Ninth Annual Boston Cross Sector 1x1 Conference. The company’s CEO and Chief Administrative Officer will hold investor meetings to discuss its strategic communications services. PPHC operates globally, serving about 1,500 clients across major economi…
Agios Pharmaceuticals announced that its Phase 2b trial of tebapivat in patients with lower-risk myelodysplastic syndromes (LR-MDS) did not meet predefined efficacy criteria to support further development for this indication. Although tebapivat was well tolerated with no new safety issues, clinical benefit was insufficient to justify continuing the…
Picard Medical, Inc. reported significant progress in 2025 and early 2026, including revenue growth, improved gross margins, and successful debt reduction. The company is advancing its SynCardia Total Artificial Heart and developing the next-generation Emperor TAH, with clinical trials underway and potential FDA submissions planned. Efforts focus o…
Seer, Inc. has filed a complaint with the US International Trade Commission against Nanomics Biotechnology Co., Ltd., alleging infringement of Seer's patents related to nanoparticle protein enrichment technology. The complaint seeks an exclusion order to bar Nanomics' products from entering the US market. This action complements an earlier federal …
Click Holdings Limited (NASDAQ: CLIK) announced the acquisition of a Hong Kong-based digital HR solutions company specializing in the construction industry. This strategic move expands Click's AI-powered HR offerings into a large, underserved segment with over 110,000 construction workers in Hong Kong. The combined platform integrates salary paymen…
Stellantis has no immediate plans to broaden its recently announced cooperation agreements with Jaguar Land Rover and Tata Motors into the European market, the group's head of Europe said. While analysts have speculated the partnerships could support European operations, management says Europe was not the original target for those joint ventures an…
Deutsche Bank lowered ratings for four UK retailers and adjusted price targets across its coverage, citing uncertainty about how inflation will affect consumer spending and retailer margins. The bank flagged weaker consumer confidence since March and a slowdown in retail spending in April, while noting retailers are better positioned than in 2022 o…
Pharvaris, a Nasdaq-listed biopharmaceutical company, announced the acceptance of multiple abstracts related to its oral bradykinin B2 receptor antagonist, deucrictibant, for presentation at the EAACI Annual Congress 2026. The presentations will showcase positive Phase 3 RAPIDe-3 trial results for on-demand treatment of hereditary angioedema (HAE) …
Li Auto shares fell sharply after the company's Q1 2026 report showed a deterioration in profitability despite revenues and deliveries that met or exceeded some expectations. Management forecast weaker second-quarter revenue and gave delivery guidance that implied a year-over-year decline, prompting analyst price-target cuts and a wave of selling t…
Japan's Ministry of Finance reported that authorities spent 11.7 trillion yen, roughly $73.5 billion, on foreign exchange intervention over the past month to prop up the yen. Officials are understood to have intervened around the turn of the month, including during Golden Week when liquidity was thin. Despite the outlay, the yen has returned to lev…
Early optimism over reports of a potential 60-day U.S.-Iran ceasefire and a prospective reopening of the Strait of Hormuz sent oil prices tumbling this week, yet market attention largely shifted to a rally in chip stocks and broader equity gains. Traders remain guarded as Treasury yields and inflation data complicate the outlook for interest rates …
